Evidence map›Paper›PMID 35762022›Full record

ArticleBasic & clinical pharmacology & toxicology2022

Statin use before and after the KDIGO Lipids in chronic kidney disease guideline: A population-based interrupted time series analysis.

Jan D Kampmann, Mads Nybo, Frans Brandt, Henrik Støvring, Per Damkier, Daniel P Henriksen, Lars C Lund

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jan D KampmannInternal Medicine Research Unit, University Hospital of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0002-8844-8242
Mads NyboDepartment of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.
Frans BrandtInternal Medicine Research Unit, University Hospital of Southern Denmark, Odense, Denmark.
Henrik StøvringBiostatistics, Department of Public Health, Aarhus University, Aarhus, Denmark.
Per DamkierDepartment of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0003-0591-7187
Daniel P HenriksenDepartment of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
Lars C LundClinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
University of Southern Denmark · DKOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In November 2013, the Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease was published, recommending statins for all individuals 50 years or older with an estimated glomerular filtration rate below 60 ml/min/1.73 m

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsRenal Insufficiency, ChronicGlomerular Filtration RateHumansInterrupted Time Series AnalysisLipidsHydroxymethylglutaryl-CoA Reductase InhibitorsLipidschronic kidney diseaseguidelinesstatins

Identifiers

PMID35762022
PMCPMC9795967
OpenAlexW4283653319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.